Plasma sgp130 is an independent predictor of non-alcoholic fatty liver disease severity

Aysim Gunes, Laurent Bilodeau, Catherine Huet, Assia Belblidia, Cindy Baldwin, Jeanne-Marie Giard, Laurent Biertho, Annie Lafortune, Christian Yves Couture, Bich N Nguyen, Eithan Galun, Chantal Bémeur, Marc Bilodeau, Mathieu Laplante, An Tang, May Faraj, Jennifer L. Estall
doi: https://doi.org/10.1101/2022.01.10.22268968

Article Information

doi 
https://doi.org/10.1101/2022.01.10.22268968
History 
  • January 11, 2022.

Article Versions

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.

Author Information

  1. Aysim Gunes1,2,3,
  2. Laurent Bilodeau4,
  3. Catherine Huet4,
  4. Assia Belblidia4,
  5. Cindy Baldwin1,
  6. Jeanne-Marie Giard5,
  7. Laurent Biertho6,7,
  8. Annie Lafortune6,7,
  9. Christian Yves Couture6,8,
  10. Bich N Nguyen9,
  11. Eithan Galun10,
  12. Chantal Bémeur11,12,
  13. Marc Bilodeau12,
  14. Mathieu Laplante3,13,14,
  15. An Tang4,
  16. May Faraj1,3,11 and
  17. Jennifer L. Estall1,2,3,*
  1. 1Institut de recherches cliniques de Montréal (IRCM), Montréal, Québec, Canada
  2. 2Division of Experimental Medicine, McGill University, Montreal, Quebec, Canada
  3. 3Montreal Diabetes Research Centre, Montreal, Quebec, Canada
  4. 4Département de radiologie, Centre hospitalier de l’Université de Montréal (CHUM), Montréal, Québec, Canada
  5. 5Département d’hépatologie, Centre hospitalier de l’Université de Montréal (CHUM), Département de médecine, Université de Montréal, Centre de recherche du CHUM, Montréal, Québec, Canada
  6. 6Centre de recherche de l’Institut Universitaire de cardiologie et de pneumologie de Québec, Université Laval, Québec, Canada
  7. 7Département de chirurgie, Faculté de médecine, Université Laval, Québec, Canada
  8. 8Département de biologie moléculaire, biochimie médicale et pathologie, Université Laval, Québec, Canada
  9. 9Département de pathologie et biologie cellulaire, Université de Montréal, Montréal, Québec, Canada
  10. 10Goldyne Savad Institute of Gene Therapy, Hadassah Hebrew University Hospital, Jerusalem, Israel
  11. 11Département de nutrition, Université de Montréal, Montréal, Québec, Canada
  12. 12Labo HépatoNeuro, Centre de recherche du CHUM, Montréal, Québec, Canada
  13. 13Centre de recherche de l’Institut universitaire de cardiologie et de pneumologie de Québec (CRIUCPQ), Faculté de Médecine, Université Laval, Québec, QC, Canada
  14. 14Centre de recherche sur le cancer de l’Université Laval, Université Laval, Québec, QC, Canada
  1. ↵*Correspondence and reprint requests should be addressed to: Jennifer L. Estall, PhD, Institut de Recherches Cliniques de Montreal, 110 avenue des Pins Ouest, Montreal, Quebec, H2W 1R7, Canada. Phone: 514 987 5688, Email: jennifer.estall{at}ircm.qc.ca

  1. Author Contributions: JLE and AT designed studies. CH and AB managed the NASH clinical study. L Biertho and AL designed and carried out the bariatric surgery study. AT, L Bilodeau, AG and C Baldwin acquired, analyzed and interpreted data. MF assisted with data analysis. JLE, L Bilodeau, AT, MF, ML, EG, MB, C Bémeur, MF contributed intellectual content. CYC scored liver histological samples. AG. MF and JLE wrote the manuscript. All authors reviewed the manuscript.

Back to top
Posted January 11, 2022.
Download PDF
Data/Code
Email
Plasma sgp130 is an independent predictor of non-alcoholic fatty liver disease severity
Aysim Gunes, Laurent Bilodeau, Catherine Huet, Assia Belblidia, Cindy Baldwin, Jeanne-Marie Giard, Laurent Biertho, Annie Lafortune, Christian Yves Couture, Bich N Nguyen, Eithan Galun, Chantal Bémeur, Marc Bilodeau, Mathieu Laplante, An Tang, May Faraj, Jennifer L. Estall
medRxiv 2022.01.10.22268968; doi: https://doi.org/10.1101/2022.01.10.22268968
Twitter logo Facebook logo LinkedIn logo Mendeley logo
Citation Tools

Subject Area